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Abstract
The AP-1–binding sequences are promoter/enhancer elements that play an essential role in the induction
of many genes in mammalian cells; however, the number of genes containing AP-1 sites remains unknown.
In order to better address the overall eﬀect of AP-1 on expression of genes encoded by the entire genome, a
genome-wide analysis of the frequency and distribution of AP-1 sites would be useful; yet to date, no such
analysis of AP-1 sites or any other promoter/enhancer elements has been performed. We present here our
study of the consensus AP-1 site and two single-bp variants showing that the frequency of AP-1 sites in
promoter regions is signiﬁcantly lower than their average rate of occurrence in the whole genomic sequence,
as well as the frequency of a random heptanucleotide suggesting that nature has selected for a decrease in
the frequency of AP-1 sites in the regulatory regions of genes. In addition, genes containing multiple AP-1
sites are more prevalent than those containing only one copy of an AP-1 site, which again may have evolved
to allow for greater signal ampliﬁcation or integration in the regulation of AP-1 target genes. However,
the number of AP-1–regulated genes identiﬁed in various studies is far smaller than the number of genes
containing potential AP-1 sites, indicating that not all AP-1 sites are activated in a given cell under a given
condition, and is consistent with the prediction by others that cellular context determines which AP-1 sites
are targeted by AP-1.
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1. Introduction
A remarkable fact in any given cell is that regulation of
genes in the entire genome can be coordinated with such
accuracy that homeostasis can be achieved during cell
proliferation, diﬀerentiation, and development. Studies
have demonstrated that the coordination between gene
expression at diﬀerent levels (transcription, mRNA stabi-
lization, translation, etc.) and the interaction of diﬀerent
regulatory factors at each level enables cells to respond
in a purposeful manner to the virtually inﬁnite variety
of developmental and environmental signals. One of the
most important steps in gene expression is transcription.
Transcription is controlled by the combinatorial action
of multiple regulatory DNA elements in each gene (pro-
moter/enhancers), and regulatory proteins (transcription
factors) that interact with these DNA elements in the reg-
ulatory regions. Numerous short DNA sequences (pro-
moter/enhancer elements) that are selectively recognized
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by diﬀerent transcription factors have been identiﬁed in
mammalian genes. The completion of the human genome
project has made it possible to determine the frequency
and distribution of diﬀerent promoter/enhancer elements
throughout the entire genome and within the promoter
regions of diﬀerent genes. Although an understanding
of how cellular regulatory machinery regulates all the
genes encoded in the entire genome is a lengthy pro-
cess that requires studies on all aspects of cellular func-
tions, determination of the frequency and distribution
of promoter/enhancer elements is an initial and informa-
tive step towards the ultimate understanding of how cells
achieve a coordinated genome-wide response in transcrip-
tion to diﬀerent environmental and developmental cues.
One of the promoter/enhancer elements that has been
extensively studied is the activator protein-1 (AP-1)
binding site.1–3 In fact, the study of the AP-1 site and its
regulatory factors played a pioneering role in the history
of the elucidation of gene transcriptional regulation.1,2
AP-1 was ﬁrst identiﬁed as a transcription factor that
binds to an essential cis-element of the human metal-
lothionein IIa promoter.1 Soon after, the binding site for
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AP-1 was also recognized as the TPA (tetradecanoyl-
phorbol-13-acetate) response element (TRE) of several
cellular and viral genes.2 The consensus sequence of the
AP-1 binding sites has been deﬁned as TGA(C/G)TCA
based on DNAase I protection analyses of TRE elements
in diverse genes.1,2 However, the AP-1–binding sites ex-
hibit some degree of degeneracy.4 It is now clear that
gene transcription via the AP-1–binding site participates
in the regulation of a variety of cellular processes includ-
ing cell proliferation, cell diﬀerentiation, cytokine pro-
duction, apoptosis and oncogenesis.4–7 The transcrip-
tion factors known to bind AP-1 sites include jun fam-
ily (c-Jun, JunB, and JunD) and fos family members.
The jun family members can either form homodimers
or heterodimers among themselves or dimerize with the
fos family members. These homodimeric jun or het-
erodimeric jun-fos complexes can then bind to AP-1 sites,
resulting in enhanced transcription.4–7 Moreover, it has
also been shown that diﬀerent jun or jun-fos dimers may
have diﬀerent DNA binding aﬃnities for AP-1 sites and
that minor sequence variations of these AP-1 sites may
result in selective binding of either jun homodimers or
jun-fos heterodimers.4,8 AP-1 transcriptional activity is
also known to be regulated by the protein levels and post-
translational modiﬁcation of jun and fos family member
proteins.7 Furthermore, the JNK, Erk and p38 MAP ki-
nase pathways have all been implicated in the regulation
of either the protein levels of AP-1 transcription factors
or phosphorylation of them, thus yielding a higher or-
der of complexity in the function of the AP-1 regulatory
sites.9–11 Increasing the complexity of AP-1 regulatory
site function still further is the growing number of AP-1–
interacting proteins that have been identiﬁed, which are
likely determinants of speciﬁc biological responses.12
In light of the signiﬁcance of AP-1 sites, an evaluation
of the frequency and distribution of AP-1 sites in the hu-
man genome and gene promoter regions should yield use-
ful information for eventually understanding how cellular
machinery controls the expression of genes encoded in the
entire genome. We ﬁrst analyzed the frequency and dis-
tribution of the consensus AP-1–binding site (TRE) and
found that the frequency of TRE in promoter regions is
signiﬁcantly lower than the overall rate of occurrence in
the genome as a whole, and the same is also true for the
frequency of a random heptanucleotide. Because of the
degeneracy in the sequences of AP-1 recognition sites,
some variants of the consensus AP-1 site also play a role
in AP-1–regulated gene expression.4,8 We therefore an-
alyzed the frequency and distribution of two variants of
the consensus AP-1 site and reached a similar conclusion
to that drawn with the analysis of the consensus TRE
sequence. Furthermore, we found that genes containing
multiple AP-1 sites occur more frequently than would
be predicted from an even distribution among AP-1 site-
containing genes. Lastly, we showed that the two variants
of TRE used in our analysis do, in fact, function as AP-
1–binding sites, regulating gene expression in response to
extracellular stimuli.
2. Materials and Methods
2.1. Analysis of AP-1 sites in human genome and
promoter regions of genes
The Blast program in NCBI (bl2seq) was used
to identify the frequency of heptanucleotide sequence
TGACTCA (TRE), TGAATCA (termed A-TRE) and
TGACTAA (termed AA-TRE). In order to identify 100%
of the matches for the short heptamers, we set the
parameter “expect” value to 109. The blast against
the AP-1 sites we selected was performed for sequences
of each contig on all 24 human chromosomes. Since
there are still gaps in the human genome database,
there was a small portion of human genomic sequence
that could not be analyzed. The promoters in the
genes of randomly picked chromosomes 8, 13, 15, 18,
20, 21, 22, X, and Y were analyzed using a 5-kb 5′
sequence directly upstream of the transcription initi-
ation site in each gene and blasted against each of
the three AP-1 sequences we selected. A total of
2960 promoters have been analyzed. The pre-masked
human genome service (http://repeatmasker.org/cgi-
bin/AnnotationRequest) was used to obtain all repeat
sequences from chromosomes 8, 13, 15, 18, 20, 21, 22, X,
and Y. These repeat sequences were then put into the
BLAST align program (bl2seq) and blasted against ei-
ther TRE, A-TRE or AA-TRE, with the “expect” value
set to 106 and the “word size” value set to 7.
2.2. Statistical Analysis
Chi-squared tests were performed using the equation
Σ(O−E)2/E to determine whether observed frequen-
cies (O) diﬀered from expected frequencies (E). Chi-
squared values above standard critical Chi-square val-
ues for a signiﬁcant probability level (i.e., 0.05) indi-
cate a deviation from expected frequencies. Correla-
tion analyses were calculated using the equation γ =
(Σxy−(ΣxΣy/n)√(Σx2−(Σx)2/n)(Σy2−(Σy)2/n) where
γ is the Pearson correlation coeﬃcient and n is the num-
ber of chromosome samples. Pearson correlation coeﬃ-
cients indicate the strength of a linear relationship with
−1 equal to perfect negative correlation and +1 equal
to perfect positive correlation. The Mann-Whitney Test
(U) was used to determine whether two populations dif-
fer with respect to central tendency using the equation
Ua=nanb+na(na+1)/2−ΣRa where n equals the number
of samples from respective group and ΣRa equals the sum
of the ranks from sample a. The populations diﬀer if the
smaller of the calculated values of U is equal to or smaller
than the table value at the desired level of α (i.e., 0.05
or 0.001). Z-Scores were calculated to determine how
far from the mean, in terms of standard deviations, our
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Figure 1. Plots of the frequencies of TRE-f, TRE-r, and TRE-f+TRE-r (TRE-f/r) in the 24 diﬀerent human chromosomes.
observations lie using the equation Z=(χ−µ)/σ, where
equals the mean and σ equals the standard deviation.
With a negative Z-score, the observation lies below the
mean and with a positive Z-score, the observation lies
above the mean. Conﬁdence intervals (95%) were calcu-
lated using the equation =1.96
√{px x (1-px)/n}16 where
px equals the TRE percentage, and n equals the number
of analyzed promoter regions.
2.3. Reporter vectors
HindIII-Bgl II oligonucleotides containing seven re-
peats of TRE, A-TRE, or AA-TRE were inserted into
a cis-reporter backbone (Stratagene, San Diego, CA).13
2.4. Cell culture and transfections
RAW 264.7 cells were maintained in Dulbecco mod-
iﬁed Eagle medium plus 10% fetal bovine serum. All
plasmid DNA used in transfection experiments was pre-
pared using CsCl2-gradient ultracentrifugation. Any po-
tential LPS and other bacterial sugar/lipid contamina-
tion was subsequently removed with Endotoxin Removal
Aﬃnity Resin (Associates of Cape Cod, Falmouth, MA).
Transfection of RAW 264.7 cells was achieved through
the calcium phosphate precipitation technique and in-
cluded glycerol shock. An empty pcDNA3 vector was
used to normalize the amount of total DNA used in each
transfection to 3 µg/well in 6-well plates. LPS (10 ng/ml)
or TPA (100 ng/ml) was applied 24 h after transfection
for diﬀerent time periods, as indicated in Fig. 1. The cells
were washed in PBS before harvesting, and resuspended
in 100 µl of a reporter lysis buﬀer (Promega, Madison,
WI). Lysed cells were brieﬂy centrifuged, and the relative
strength of reporter induction was calculated by measur-
ing the luciferase activity of the supernatant using a lumi-
nometer in a luciferase assay reagent (Promega). Trans-
fection eﬃciency was normalized by co-transfecting cells
with an expression plasmid containing a CMV promoter-
driven β-galactosidase reporter. β-Galactosidase activ-
ity was measured by using the chemiluminescent assay
Galacto-Light (Tropix, Bedford, MA) or by using O-
nitrophenyl-β-D-galactopyranoside (ONPG) as follows:
20 µl of lysis supernatant was added to 80 µl of 3.5 mM
ONPG solution, incubated at 37◦C for 30 min, and ab-
sorbance was measured at 405 nm.
3. Results
3.1. Frequency of consensus AP-1-binding site (TRE)
in the human genome
In order to better assess the contribution of AP-1 tran-
scription factor in overall gene expression, we thought
to analyze the frequency and distribution of AP-1 bind-
ing sites in the human genome. Since TRE is a double-
stranded DNA sequence that reads 5′-TGACTCA-3′ and
the other strand 5′-TGAGTCA-3′, we designated them
as TRE-f (for forward), and TRE-r (reverse). We an-
alyzed the frequency of TRE-f and TRE-r sequences of
TRE independently in each of the 24 human chromo-
somes. As summarized in Fig. 1, both TRE-f and TRE-r
are similarly present in all human chromosomes based on
the Chi-squared test (χ2=0.227 and 0.193, respectively,
d.f.=1, P >0.05). Furthermore, there is a strong corre-
lation between the frequency of TRE-f and TRE-r using
the Pearson correlation test (γ =0.869, n=24, P <0.01),
which is consistent with the fact that TRE-f and TRE-r
are complementary sequences. The frequencies of TRE-f
and TRE-r calculated for the entire human genome were
8.08×10−5 and 8.12×10−5, respectively. Since the fre-
quency of a random heptanucleotide with the same GC
content as TRE is 6.52×10−5, based on the published
data that genomic GC content is 41%,14 the frequencies
of both TRE-f and TRE-r are substantially higher than
the frequency of the random heptanucleotide.
3.2. Frequency of TRE in promoter regions
The available human genome sequence has made it
possible to analyze the frequency of TRE in the pro-
moters of diﬀerent genes. However, it would be very
time consuming to analyze the promoters of each of the
more than 30,000 genes in the whole genome. Since the
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Figure 2. The frequencies of TRE-f, TRE-r, and TRE-f+TRE-r (TRE-f/r) in the promoters located on chromosomes 8, 13, 15, 18, 20,
21, 22, X, and Y.
genome-wide analysis of TRE sites yielded similar results
in the frequency of TRE sites in diﬀerent chromosomes
(Fig. 1), an analysis of several chromosomes for the fre-
quency of TRE sites in promoter regions should provide
reliable information regarding the occurrence of TRE in
all promoter regions. In order to obtain statistically re-
liable data we randomly picked chromosomes 8, 13, 15,
18, 20, 21, 22, X, and Y for an analysis. We analyzed
all deﬁned genes in each of these chromosomes for the
frequency of TRE sequences in promoter regions. We
selected a 5-kb sequence upstream of the predicted tran-
scriptional initiation sites as the promoter region in our
analysis. The frequencies of TRE in the 5-kb promoter
region of genes in chromosomes 8, 13, 15, 18, 20, 21,
22, X, and Y were calculated and are shown in Fig. 2.
The distribution of TRE-f and TRE-r in the promoter
regions of genes is similar in the chromosomes analyzed
using the Chi-square test (χ2 =0.728 and 1.431, respec-
tively, d.f.=1, P >0.05). The overall frequencies of TRE-
f and TRE-r are 5.95×10−5 and 5.93×10−5, respectively.
These are both 25% less than their frequency in the whole
genome (8.08×10−5 and 8.12×10−5, respectively). Since
GC content in promoters may inﬂuence the frequency of
TRE in the promoter regions, we measured the average
GC content in the promoters analyzed in this study and
found it to be 45.8%, which is almost the same as the
value of 46% reported in a study of regulatory signals.14
Therefore, the overall frequencies of TRE-f and TRE-r
are also lower than the frequency of a random heptanu-
cleotide (6.46×10−5), based on a GC content of 46% in
the promoter region.
We have analyzed statistical signiﬁcance between the
genomic frequency of TRE and the frequency of TRE in
the promoter regions (Fig. 3). The P -values of Chi square
tests were all less than 0.05 when TRE-f (Fig. 3A), TRE-
r (Fig. 3B) or TRE-f+TRE-r (Fig. 3C) were analyzed,
conﬁrming that TRE has diﬀerent frequencies in the pro-
moter region compared with the whole genome. The
same conclusion was obtained through a Mann-Whitney
test. Thus, we concluded that the distribution of TRE is
not uniformly distributed in the whole genome and the
frequency of TRE in the promoter region is less than the
overall frequency of TRE in the whole genome.
3.3. Frequency of TRE in repeat-masked sequences
Sequence repeats are found in varying abundance in
most genomes. It is known that these repeats are
distributed throughout the genome but their function
is largely unknown. We used the pre-masked human
genome service in the repeatmasker program (http://
repeatmasker.org/cgi-bin/AnnotationRequest) to obtain
all repeat sequences from chromosomes 8, 13, 15, 18, 20,
21, 22, X, and Y and analyzed the frequency of TRE-f
and TRE-r in these repeats. As shown in Fig. 4, the dis-
tribution of TRE-f and TRE-r in the repeat-masked re-
gions is similar among the chromosomes when analyzed
using a Chi-square test (χ2 =0.112 and 0.483, respec-
tively, d.f.=1, P >0.05). The overall frequencies of TRE-
f and TRE-r are 7.31×10−5 and 7.26×10−5, respectively.
These are higher than their frequency in the promoter
regions (5.95×10−5 and 5.93×10−5, respectively) and
slightly lower than their frequency in the whole genome
(8.08×10−5 and 8.12×10−5, respectively). There is no
statistical signiﬁcance in the diﬀerence between the ge-
nomic frequency of TRE and the frequency of TRE in
the repeat-masked regions as the P−values of Chi square
tests are all above 0.05 when TRE-f , TRE-r, or TRE-
f+TRE-r were analyzed.
3.4. Distribution of TRE in human genes
We calculated the percentages of genes that contain
TRE in their promoter regions and summarized this data
in Table 1. Approximately 24% of the analyzed genes
contain TRE in the forward direction and 24% in the
reverse direction. The calculated frequency of TRE-
f (or TRE-r) in the promoters we examined is 25.7%
[1−(1−5.95×10−5)5000] if TRE-f (or TRE-r) occurred
uniformly in diﬀerent promoters. Assuming that the an-
alyzed promoter regions (2960 out of ∼ 34,000 genes in
whole genome) were randomly selected, we can extrap-
olate with a 95% conﬁdence interval that 24%±1.5% of
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Figure 3. Comparison of the frequencies of TRE-f (A), TRE-r (B), and TRE-f+TRE-r (C) in the genome and in promoters.
Figure 4. The frequencies of TRE-f, TRE-r, and TRE-f+TRE-r in the repeat sequences located on chromosomes 8, 13, 15, 18, 20, 21,
22, X, and Y.
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Table 1. Percentage of genes containing TRE sequence in their promoter.
                                         
                                                                                 
                                                                                 
                                                                                                  
Table 2. Percentage of promoters containing single and multiple TRE.
 
                                                       
                                                                    
                                                                    
                                                                    
                                             
                                                                   
                                                   
                                              
                                   
                                      
the gene promoters contained at least one TRE site15,16
(px =0.24, n=2960). The Chi-square test also showed
that the diﬀerence between 25.7% and 24% is not signif-
icant (P >0.05). Thus, the TRE sequences are evenly
distributed among the promoters of diﬀerent genes.
Table 2 summarizes the percentage of genes containing
single and multiple TREs in their promoter regions. Us-
ing the Chi-square test, all categories except the category
of promoters containing one copy of TRE-r (χ2 =6.83,
d.f.=1, P <0.05) show an even distribution among chro-
mosomes (χ2 =3.84, d.f.=1, P >0.05). Actually, TRE-r
is evenly distributed among 8, 13, 15, 18, 20, 21, 22,
and X chromosomes and it is unclear whether the low
frequency of TRE-r on the Y chromosome has any phys-
iological signiﬁcance. About 20% of TRE-f — or TRE-r
— containing genes have more than one TRE-f or TRE-
r, respectively. Since TRE-f and TRE-r are complemen-
tary sequences and function identically, the total number
of TRE-f and TRE-r is more physiologically relevant. As
shown in Table 2, more than one-third of TRE-containing
genes have more than one TRE when the direction of
TRE was not considered. Indeed, calculating Z-scores
associated with binomial distributions for TRE-f and/or
TRE-r show that genes with only one copy are the most
underrepresented category (Z=−38.8, x=740, µ=1776,
σ=26.65) while those having greater than two copies are
the least underrepresented (Z=−7.38, x=118.4, µ=224,
σ=14.4).
3.5. Selection of variants of consensus AP-1 recognition
sequences for frequency and distribution analysis
Since the AP-1 transcription factors do not only bind
to a consensus DNA sequence but also to some DNA
sequences that diﬀer slightly from the consensus AP-1
site,1,2,4,8 variant AP-1 binding sites need to be consid-
ered in order to understanding the overall expression of
AP-1-dependent genes. Since TRE possess a twofold ro-
tational (or palindromic) symmetry, a mutation at po-
sition 1 or 7, 2 or 6, and 3 or 5 can be considered as
the same. Thus, there are ten single-base variants of the
TRE sequence; however, not all variants can function as
an AP-1 recognition site. For example, substitution of a
base at position 1, 3, or 5 has been shown to diminish AP-
1 sequence-mediated reporter gene expression.1,2,17 Since
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Figure 5. Comparison of the genomic frequencies between TRE-f and A-TRE-f (A), TRE-f and AA-TRE-f (B), or AA-TRE-f and
A-TRE-f (C).
there is no conclusion as to how many AP-1 site variants
can function as AP-1 recognition sites, it is improbable
for us to determine the frequency of every AP-1 recog-
nition site. Therefore, we selected for our analysis two
AP-1 site variants that are known to function as AP-1
recognition sites. A-TRE, a TRE variant with A instead
of C or G at position 4 (TGAATCA) that is reported
to be selectively targeted by jun-fos heterodimer,8 was
selected in our analysis. Since both TRE and A-TRE
are palindromic sequences, we thought to include a non-
palindromic AP-1 site variant in our analysis because it
may behave diﬀerently than the palindromic sequences.
We found through a literature search a non-palindromic
TRE variant, TGACTAA,1,18 and included it in our fre-
quency and distribution analysis.
3.6. Frequency of A-TRE and AA-TRE in the human
genome
Since the frequencies of TRE-f and TRE-r are about
the same (Fig. 1) and our small scale test also showed
that the diﬀerence of frequency between the two ori-
entations of A-TRE or AA-TRE was less than 0.5%
(data not shown), we only analyzed the forward se-
quences of A-TRE and AA-TRE in the human genome.
The overall frequency of A-TRE-f in the human genome
is 8.81×10−5, lower than the frequency of the random
heptanucleotide of the same GC content (9.38×10−5).
Pearson correlation analysis indicated that the distribu-
tion of A-TRE-f is not correlated with that of TRE-f
(γ = −0.369, n=24, P <0.01) (Fig. 5A). Although the
variation of the frequency of A-TRE-f among diﬀerent
chromosomes is larger than that of TRE-f with a range of
5.70×10−5 to 9.49×10−5, the Chi-square test suggested
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Figure 6. The frequencies of A-TRE-f and AA-TRE-f in the promoters located in chromosomes 8, 13, 15, 18, 20, 21, 22, X, and Y.
Figure 7. The frequencies of A-TRE-f and AA-TRE-f in the repeat sequences located on chromosomes 8, 13, 15, 18, 20, 21, 22, X, and
Y.
that A-TRE-f still should be considered as uniformly dis-
tributed across diﬀerent chromosomes (χ2 =2.57, d.f.=1,
P >0.05).
The frequency of AA-TRE-f is lower than TRE-f and
A-TRE-f in each of the human chromosomes with an
overall frequency of 6.07×10−5 (Fig. 5B), which is also
much lower than the frequency of the random heptanu-
cleotide of the same GC content (9.38×10−5). The dis-
tribution of AA-TRE-f in diﬀerent chromosomes is sim-
ilar based on the Chi-square test (χ2 =2.62, d.f.=1,
P >0.05). The frequency of AA-TRE-f is not correlated
under the Pearson correlation test with that of TRE-
f (γ = −0.496, n=24, P <0.01) (Fig. 5B), but does
show strong correlation with A-TRE-f (γ =0.874, n=24,
P <0.01) (Fig. 5C).
3.7. Frequency of A-TRE and AA-TRE in promoter
regions
We searched for sequences of A-TRE-f and AA-TRE-
f in the 5-kb promoter region of genes on chromosomes
8, 13, 15, 18, 20, 21, 22, X, and Y. The frequencies of
A-TRE-f and AA-TRE-f were calculated and shown in
Fig. 6. Both A-TRE-f and AA-TRE-f are evenly dis-
tributed in the chromosomes analyzed using a Chi-square
test (χ2 =3.65 and 1.30, respectively, d.f=1, P >0.05).
Similar to the frequency and distribution of TRE (Figs. 1
and 2), A-TRE and AA-TRE occurred much less fre-
quently in the promoter regions in comparison with the
whole genome (Figs. 5 and 6). The overall frequency
of A-TRE-f and AA-TRE-f in the promoter regions is
5.15×10−5 and 3.43×10−5, respectively. These are lower
than the frequency of a random heptanucleotide of the
same GC content (7.59×10−5). As mentioned earlier, the
lower frequency of AP-1 sites in the promoter regions may
be a result of natural selection pressure restricting the
number of AP-1 sites in the regulatory region of genes.
If this is the case, AA-TRE was most aﬀected in the AP-1
recognition sites we have analyzed.
3.8. Frequency of A-TRE and AA-TRE in repeat-
masked sequences
The repeat sequences selected by repeatmasker pro-
gram from chromosomes 8, 13, 15, 18, 20, 21, 22, X,
and Y were analyzed for the frequency of A-TRE-f and
AA-TRE-f. As shown in Fig. 7, the distribution of
A-TRE-f and AA-TRE-f in the repeat-masked regions
is similar in the chromosomes analyzed using a Chi-
square test (χ2 = 0.441 and 0.657, respectively, d.f.=1,
P >0.05). The overall frequencies of A-TRE-f and
AA-TRE-f are 6.19×10−5 and 4.42×10−5, respectively.
These are higher than their frequency in the promoter re-
gions (5.15×10−5 and 3.43×10−5, respectively) and lower
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Table 3. % of genes containing A-TRE or AA-TRE sequence in their promoter.
                                         
                                                                                             
                                                                                        
Table 4. % of promoters containing single or muliple of TRE, A-TRE and/or AA-TRE.
  
                                                       
                                                         
                                                     
                                                       
                                                       
                                                         
                                                       
                                                   
                                                 
                                                  
than their frequency in the whole genome (8.81×10−5
and 6.07×10−5, respectively). The diﬀerences are all sta-
tistically signiﬁcant as the P -values of Chi-square tests
are all less than 0.05.
3.9. Distribution of A-TRE and AA-TRE in human
genes
We calculated the percentages of genes that contain
A-TRE or AA-TRE in their promoter regions and sum-
marized this data in Table 3. The percentage of genes
containing A-TRE or AA-TRE is 21% and 15%, respec-
tively. These frequencies are about the same as the 22%
[1−(1−5.15×10−5)5000] and 15% [1−(1−3.43×10−5)5000]
that a uniform distribution would predict.
Because the consensus AP-1 site and other AP-1 recog-
nition sites may function together in a given promoter,
we analyzed the percentage of the promoters containing
one, two, three, and more than three TRE, A-TRE-f,
and/or AA-TRE-f (Table 4). As shown in Table 4, the
number of promoters containing one of the three TREs is
only slightly higher than the promoters containing two.
Furthermore, the percentage of promoters that contain
two or more TREs is greater than the percentage of pro-
moters containing a single TRE element. It should be
noted that the percentage of promoters containing single
(1×) TRE, A-TRE and/or AA-TRE (Table 4) is even
smaller than the percentage of promoters containing 1×
TRE (Table 2) on some chromosomes, which is due to
the fact that a promoter containing one type of TRE
may also contain other TRE variants. The data in Ta-
ble 4 is incomplete because we cannot include all poten-
tial AP-1 sites in our analysis, but it still can be con-
cluded that more than half of all genes contain potential
AP-1 recognition sites. Each of the TRE sequences we
analyzed appears to be uniformly distributed in diﬀerent
promoters (Tables 1 and 3), however, the distribution of
diﬀerent AP-1 sites seems not to be independent as they
tend to be concentrated on some genes (Table 4). We
have compared all categories in Table 4 with predicted
binomial distributions. Z-Scores for both the 1×(−437)
and 2× categories (−11.75) are low, suggesting that sin-
gle or double copies of AP-1 sites are underrepresented
in the promoter region. In contrast, Z-scores for the
3×(+4.89) and >3×(+6.32) imply an overrepresentation
in promoter regions containing three or more AP-1 sites.
Diﬀerent numbers of AP-1 recognition sites in diﬀerent
genes, then, may be a mechanism that allows for the ﬁne
modulation of gene expression by AP-1 transcription fac-
tors.
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Figure 8. Comparison of TRE-, A-TRE- and AA-TRE-dependent gene expression. RAW264.7 cells were transfected with the reporter
plasmids of TRE, A-TRE, or AA-TRE. Twenty-four hours after transfection, the cells were treated with LPS (10 ng/ml) for diﬀerent
periods of time as indicated. The cells were harvested and the luciferase activity was measured.
3.10. Comparison of TRE-, A-TRE- and AA-TRE-
dependent gene expression
Since we had analyzed frequencies and distributions
of TRE, A-TRE and AA-TRE, we believed a functional
comparison of these AP-1 sites would provide important
information on the relationship between the diﬀerent se-
quences and their regulatory behaviors. To compare the
function of these three AP-1 sites in gene expression,
we constructed expression vectors of a luciferase reporter
under the control of TRE, A-TRE, or AA-TRE, respec-
tively. Since it is known that AP-1 transcriptional activ-
ity can be induced in macrophages by LPS,19 we tran-
siently transfected RAW 264.7 cells with TRE, A-TRE,
or AA-TRE reporter plasmids. The reporter gene ex-
pression was measured in cells treated with or without
LPS (Fig. 8). The basal expression of TRE-dependent
genes was over ﬁvefold higher than that of A-TRE– and
AA-TRE–dependent genes. Although LPS stimulation
increased gene expression in a time-dependent manner
for each of these three reporters, the levels of induction
were signiﬁcantly diﬀerent. The TRE reporter construct
exhibited the highest luciferase expression levels after
LPS stimulation. AA-TRE–mediated luciferase expres-
sion was about 60% of TRE expression while A-TRE–
mediated luciferase expression was dramatically lower
than that directed by TRE or AA-TRE. Due to high
basal expression levels, the fold of induction by LPS of
the TRE reporter was only one-third of that of the AA-
TRE reporter. The diﬀerences among TRE, A-TRE,
and AA-TRE in mediating reporter gene expression were
similarly seen in the cells treated with TPA (data not
shown). Thus, the nature of diﬀerent AP-1 recognition
sites as well as their distribution are important factors in
the accurate regulation of genes in biological processes.
4. Discussion
By virtue of their oncogenic origins,20 the AP-1 factors
Jun and Fos play crucial roles in controlling homeosta-
sis of cell growth.7 They must receive numerous signals
to either upregulate or downregulate gene transcription,
depending on cellular context and signals. Our analysis
of the human genome database revealed that the occur-
rence of AP-1 binding sites in promoter regions of diﬀer-
ent genes is less frequent compared with the overall rate
of occurrence in the whole genome (Figs. 1–3, 5, and
6), suggesting that natural selection has eliminated AP-
1 binding sites in the promoter region of certain genes.
The lower frequency of AP-1 sites in repeat sequences
in comparison with the overall rate in the whole genome
(Figs. 4 and 7) may be interpreted by the suggestion that
interspersed repeats are one of the hotspots for eukaryotic
chromosome evolution.21 Perhaps because the repeats are
only loosely related with gene expression,22 the frequency
of AP-1 sites in the repeats is still higher than that in
the promoter regions (Figs. 3, 4, 6, and 7). Although the
frequency of AP-1 binding sites in the promoter regions
is less than expected, there is still a considerable num-
ber of genes that have potential AP-1 recognition sites
in their promoter regions based on the observation that
about one-third of genes contain the consensus AP-1 site
in their promoter regions (Table 2). More than half of
the genes contain AP-1 recognition sites if variants of the
consensus AP-1 site are included (Table 4). In addition,
two-thirds of the genes that contain potential recognition
sites have more than one site (Table 4). Furthermore,
our data indicate that the occurrence of AP-1 sites is not
evenly distributed in the human genome and it is likely
that these sites have undergone natural selection in or-
der to meet the demand of controlled gene expression in
the cell (Table 4). Since the number and diversity of
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genes containing AP-1 sites is so large, it is impossible
to precisely categorize what types of gene will contain
AP-1 sites. Nevertheless, the information regarding the
frequency and distribution of AP-1 sites obtained in our
analysis has provided some useful information for under-
standing the overall contribution of AP-1 sites in gene
regulation.
A number of AP-1 site variants have been reported to
function as AP-1 binding sites and some diﬀer from the
consensus TRE sequence by two or more bases. We have
limited our analysis to single-base variants of TRE be-
cause sites of further deviation behave drastically diﬀer-
ent from the consensus AP-1 sequence4 and are beyond
the scope of the present study. Although calculating the
percentage of genes containing multiple sites of TRE, A-
TRE, or AA-TRE cannot give a precise answer as to the
percentage of genes containing multiple copies of all AP-
1 recognition sites, this analysis does, however, provide
solid evidence that at least half of the human genes con-
tain potential AP-1 binding sites in their 5-kb upstream
sequence of their transcriptional initiation site. In addi-
tion, our data are reliable for interpreting whether AP-1
sites tend to be uniformly distributed or selectively con-
centrated in particular genes.
It is known that many types of genes, such as onco-
genes and genes coding for cytokines and metallopro-
teinases, are targeted by AP-1 transcription factors; how-
ever, it is still not clear whether AP-1 recognition sites
are concentrated on certain type of genes compared with
the rest of the genome. AP-1 sites are indeed found in
cytokine genes, oncogenes, and metalloproteinase genes;
however, there are many other types of genes — such as
defensins, translation factors, ring-ﬁnger proteins — that
contain AP-1 sites as well in their promoters. Perhaps as
a result of gene duplication, AP-1 sites are often found in
all or most members of a gene family. For example, pro-
moters of the 26 solute carrier family members located
on chromosomes 8, 13, 15, 18, 20, 22, and X all contain
potential AP-1 recognition sites. Thus, AP-1 sites are
more frequently found in certain genes.
The results of various experiments indicate that the
number of genes induced by AP-1 factors in any given
condition is far less than half the number of genes in
the cell.4,23–25 Thus, only a small subset of genes that
contain potential AP-1 regulatory sites are activated by
AP-1 transcription factors in a particular cell at a given
time. This is not surprising since many AP-1 sites may
not be accessible due to chromatin structures. Further-
more, gene expression in mammalian cells is controlled
by multiple transcription factors, and the binding of the
AP-1 transcription factor to a gene may not be suﬃcient
by itself to turn on transcription. Since the sequences
surrounding AP-1 sites have been shown to play an im-
portant role in directing the orientation of AP-1 tran-
scription factor binding26 and the interaction of AP-1
transcription factor with other transcription factors,4 the
ﬂanking sequence of an AP-1 site(s) in a given gene needs
to be considered. It is clear that whether or not a poten-
tial AP-1 site functions in gene expression should depend
on the particular cellular context, while the identiﬁcation
of AP-1 sites provides a basis for further analysis.
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